Aktuelle Aspekte in der Therapie des Vorhofflimmerns – „Highlights“ der DGK-Jahrestagung 2015

Atrial fibrillation (AF) is the most common arrhythmia prompting clinical presentation. Of the available pharmacologic and non-pharmacologic treatment options, the fastest growing and most intensely studied is catheter-based ablation therapy for AF. Pulmonary vein isolation is the cornerstone of catheter ablation of paroxysmal AF. Meanwhile, the optimal ablation strategy beyond PVI in peristent AF remains to be elucidated. Several ablation approaches targeting the morphological or/and the functional substrate of AF are currently under investigation. Planning and evaluation of these novel ablation strategies needs to be strictly controlled in clinical studies. The latter might be improved by using miniaturized, implantable event recorders for continuous heart rhythm monitoring